Novel approaches to reactivate pertussis immunity.


Journal

Expert review of vaccines
ISSN: 1744-8395
Titre abrégé: Expert Rev Vaccines
Pays: England
ID NLM: 101155475

Informations de publication

Date de publication:
12 2022
Historique:
pubmed: 19 11 2022
medline: 2 12 2022
entrez: 18 11 2022
Statut: ppublish

Résumé

Whole cell and acellular pertussis vaccines have been very effective in decreasing the deaths of neonates and infants from This review discusses the different possibilities for improving current pertussis vaccines and the present state of knowledge on the pertussis vaccine candidates under development. Until there is a safe, effective, and affordable alternative to the two types of existing vaccines, we should maintain sufficient childhood coverage and increase the vaccination of pregnant women, adolescents, and young adults.

Identifiants

pubmed: 36400443
doi: 10.1080/14760584.2022.2149499
doi:

Substances chimiques

Vaccines, Attenuated 0

Types de publication

Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1787-1797

Auteurs

Geraldine Blanchard-Rohner (G)

Center of Vaccinology, Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Unit of Immunology and Vaccinology, Division of General Pediatrics, Department of Pediatrics, Gynecology and Obstetrics, Geneva University Hospitals, University of Geneva, Geneva, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH